InvestLog
BCRX BioCryst Pharmaceuticals, Inc. logo

BCRX BioCryst Pharmaceuticals, Inc.

Healthcare
$8.47+2.17%ClosedMarket Cap: $1.78B

As of 2026-05-26

Insider Statistics (Q2 2026)

Acquisitions

3

Dispositions

3

Buy/Sell Ratio

1.00

Net Shares

+572,820

Shares Acquired

709,000

Shares Disposed

136,180

Total Bought ($)

$0.00

Total Sold ($)

$2.00

Recent Insider Trades
Filing DateNameTypeActionSharesPriceShares After
Tue May 19McKee Amy EdirectorSell11,180$8.9731,252
Fri May 15Barnes Alane Pofficer: Chief Legal OfficerSell62,500$9.54400,703
Fri May 15Barnes Alane Pofficer: Chief Legal OfficerSell62,500$5.04463,203
Tue Apr 07Menon Sandeepofficer: Chief R&D OfficerSell441,350$9.47441,350
Tue Apr 07Menon Sandeepofficer: Chief R&D OfficerSell205,150$0.00205,150
Tue Apr 07Menon SandeepofficerSell0$0.000
Tue Mar 24HEGGIE THERESAdirectorSell49,933$10.1165,352
Tue Mar 24HEGGIE THERESAdirectorSell49,933$6.30115,285
Wed Mar 18Barnes Alane Pofficer: Chief Legal OfficerSell150,000$9.15400,703
Wed Mar 18Barnes Alane Pofficer: Chief Legal OfficerSell150,000$5.51550,703
Tue Mar 03Stonehouse Jon PdirectorSell305,995$3.221,629,845
Tue Mar 03Stonehouse Jon PdirectorSell305,995$8.641,323,850
Tue Mar 03Stonehouse Jon PdirectorSell421$8.751,323,850
Tue Mar 03Milne Jill C.directorSell528$8.7515,382